• By inhibiting both COX-2 and 5-LOX expression and stimulating the negative regulator β-arrestin 2 through an MAPKs-dependent mechanism, flavocoxid may represent a potential new approach to the treatment of sepsis. The gene discussed is PTGS2; the disease is Sepsis.